We have considered patient sub-samples characterized by either particular prognostic factors or clinical conditions, such as diameter of the primary cancer mass (T1 ≤ 20 mm, 20 mm < T2 ≤ 50 mm), age, grading molecular subtypes by summarizing Er, PR, ki67, and HER2. The gene discussed is ERBB2; the disease is cancer.